Zobrazeno 1 - 10
of 33
pro vyhledávání: '"dlbs3233"'
Autor:
Andon Hestiantoro, Wiryawan Permadi, Raymond R. Tjandrawinata, Budi Wiweko, Mulyanusa Ritonga, Ade Indra Ferrina, Kanadi Sumapraja, R Muharam, Tono Djuwantono
Publikováno v:
International Journal of Fertility and Sterility, Vol 18, Iss Suppl 1, Pp 35-47 (2024)
Background: A bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, DLBS3233, has recentlybeen used for type-2-diabetes treatment due to its favorable effect on insulin sensitivity. The insulin resistance leadingto metabolic syndrome
Externí odkaz:
https://doaj.org/article/dd890bd9185a4e279946973e0113321d
Autor:
Heri Nugroho, Nurmilawati Nurmilawati, Diana Novitasari, Lidia Rombeallo, Rambu Farah Effendi, Reski Reski, Intan Surayya, Nugroho Agung Daryanto, Solomon Putera, Raymond Rubianto Tjandrawinata
Publikováno v:
Acta Medica Indonesiana, Vol 56, Iss 3 (2024)
Background: DLBS3233, recognized as an agent enhancing insulin sensitivity, has exhibited promise as a therapeutic option for addressing type 2 diabetes mellitus (T2DM). This study aimed to evaluate the effectiveness and safety of DLBS3233, a natural
Externí odkaz:
https://doaj.org/article/1e6903f2b9df4964a0c4545f0721a068
Publikováno v:
International Journal of Women's Health, Vol Volume 15, Pp 971-985 (2023)
Syarief Thaufik Hidayat,1,2 Inu Mulyantoro,1,2 Suhartono Damas,3 Raymond R Tjandrawinata4 1Obstetric Gynecology Department, Faculty of Medicine, Diponegoro University, Semarang, Indonesia; 2Obstetric Gynecology Department, Dr. Kariadi Hospital, Semar
Externí odkaz:
https://doaj.org/article/bf3d5094cf4047f18acf9c7fabab0d76
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wiryawan Permadi, Andon Hestiantoro, Mulyanusa Amarullah Ritonga, Ade Indri Ferrina, Wulan Ardhana Iswari, Kanadi Sumapraia, Raden Muharram, Tono Djuwantono, Budi Wiweko, Raymond Tjandrawinata
Publikováno v:
Journal of Human Reproductive Sciences, Vol 14, Iss 1, Pp 16-20 (2021)
Background: Hyperinsulinemia, a common feature in PCOS, have been found to contribute to metabolic disturbance, such as dyslipidaemia and diabetes mellitus type 2. Oral anti-diabetic medications have been prescribed to alleviate this effect. We sough
Externí odkaz:
https://doaj.org/article/361670d2709d482293504febecd08b67
Autor:
Budi Wiweko, Cynthia A Susanto
Publikováno v:
Journal of Human Reproductive Sciences, Vol 10, Iss 1, Pp 31-36 (2017)
Background: Polycystic ovary syndrome (PCOS) is known to be associated with insulin resistance and anti-Mullerian hormone (AMH), leading to the use of insulin-sensitizing agents (ISAs) to manage PCOS. Metformin is the most widely used ISA to treat ir
Externí odkaz:
https://doaj.org/article/d78d25d28f9b4cd884dde331c2437542
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 8, Iss 2, Pp 52-58 (2017)
Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia speciosa and Cinnamomum burmannii has been successfully performed via supercritical anti-solvent (SAS) technology. The o
Externí odkaz:
https://doaj.org/article/569bfbf159dc443a85faff51d3dbf0dd
Publikováno v:
Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 1279-1289 (2016)
Asman Manaf,1 Raymond R Tjandrawinata,2 Desi Malinda1 1Department of Internal Medicine, Faculty of Medicine, University of Andalas, Dr M Djamil Padang Hospital, Padang, 2Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia Backgroun
Externí odkaz:
https://doaj.org/article/d74c0660e5914b54b7313fb05dcac9f9
Autor:
Budi Wiweko, Raden Muharram, Tono Djuwantono, Wulan Ardhana Iswari, Kanadi Sumapraia, Andon Hestiantoro, Mulyanusa Amarullah Ritonga, Raymond R. Tjandrawinata, Ade Indri Ferrina, Wiryawan Permadi
Publikováno v:
Journal of Human Reproductive Sciences, Vol 14, Iss 1, Pp 16-20 (2021)
Background: Hyperinsulinemia, a common feature in PCOS, have been found to contribute to metabolic disturbance, such as dyslipidaemia and diabetes mellitus type 2. Oral anti-diabetic medications have been prescribed to alleviate this effect. We sough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919cb22794307963c7be4e1f4cf32c72
http://www.jhrsonline.org/article.asp?issn=0974-1208
http://www.jhrsonline.org/article.asp?issn=0974-1208